Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality

Yaping Sun1, Sooryanarayana Varambally, Christopher A Maher

  • 1Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.

Blood
|April 9, 2011
PubMed

Insights

MicroRNAs (miRNAs) can regulate immune responses. Targeting miR-142-3p in dendritic cells (DCs) reduced mortality in endotoxin-induced sepsis, suggesting a novel therapeutic strategy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in immune responses.
  • The role of miRNAs in regulating endotoxin-induced inflammatory processes, like Gram-negative sepsis, remains unclear.
  • Dendritic cells (DCs) and their cytokine production are critical in responding to lipopolysaccharide (LPS).

Purpose of the Study:

  • To investigate the role of miRNAs in regulating DC responses to LPS.
  • To determine if targeting miRNAs can be a therapeutic strategy for endotoxin-induced mortality.

Main Methods:

  • miRNA and mRNA profiling of CD11c+ DCs after LPS stimulation.
  • Computational prediction and luciferase reporter assays to identify miRNA targets.
  • In vitro knockdown and overexpression studies of miR-142-3p in DCs.
  • In vivo studies using wild-type and IL-6-deficient mice treated with miR-142-3p inhibitors.

Main Results:

  • miR-142-3p was highly expressed in DCs and predicted to target IL-6 mRNA.
  • miR-142-3p specifically regulated IL-6 production by DCs in response to LPS.
  • In vivo administration of a miR-142-3p inhibitor reduced mortality in wild-type mice with LPS-induced sepsis but not in IL-6-deficient mice.

Conclusions:

  • miR-142-3p plays a critical role in regulating DC responses to LPS.
  • Targeting miR-142-3p offers a potential therapeutic approach for endotoxin-induced mortality and sepsis.

Related Concept Videos